Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2129437rdf:typepubmed:Citationlld:pubmed
pubmed-article:2129437lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C1524112lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C0014822lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2129437lifeskim:mentionsumls-concept:C1947976lld:lifeskim
pubmed-article:2129437pubmed:dateCreated1991-10-7lld:pubmed
pubmed-article:2129437pubmed:abstractTextTo evaluate the acute and long-term haemodynamic response to recombinant human erythropoietin (rHuEpo) correction of chronic anaemia in haemodialysis-supported patients.lld:pubmed
pubmed-article:2129437pubmed:languageenglld:pubmed
pubmed-article:2129437pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2129437pubmed:citationSubsetIMlld:pubmed
pubmed-article:2129437pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2129437pubmed:statusMEDLINElld:pubmed
pubmed-article:2129437pubmed:issn0931-0509lld:pubmed
pubmed-article:2129437pubmed:authorpubmed-author:ThomasTTlld:pubmed
pubmed-article:2129437pubmed:authorpubmed-author:BravoE LELlld:pubmed
pubmed-article:2129437pubmed:authorpubmed-author:PaganiniE PEPlld:pubmed
pubmed-article:2129437pubmed:authorpubmed-author:Fouad-TaraziF...lld:pubmed
pubmed-article:2129437pubmed:authorpubmed-author:AbdulhadiM...lld:pubmed
pubmed-article:2129437pubmed:issnTypePrintlld:pubmed
pubmed-article:2129437pubmed:volume5 Suppl 1lld:pubmed
pubmed-article:2129437pubmed:ownerNLMlld:pubmed
pubmed-article:2129437pubmed:authorsCompleteYlld:pubmed
pubmed-article:2129437pubmed:pagination102-8lld:pubmed
pubmed-article:2129437pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:meshHeadingpubmed-meshheading:2129437-...lld:pubmed
pubmed-article:2129437pubmed:year1990lld:pubmed
pubmed-article:2129437pubmed:articleTitleThe haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.lld:pubmed
pubmed-article:2129437pubmed:affiliationDepartment of Hypertension, Cleveland Clinic Foundation, Ohio.lld:pubmed
pubmed-article:2129437pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2129437pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2129437pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:2129437pubmed:publicationTypeMulticenter Studylld:pubmed